YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-κB and promote the malignant progression of glioma.
Rui-Chao ChaiYu-Zhou ChangXin ChangBo PangSong Yuan AnKe-Nan ZhangYuan-Hao ChangTao JiangYong-Zhi WangPublished in: Journal of hematology & oncology (2021)
Our findings confirmed that YTHDF2 promotes the malignant progression of gliomas and revealed important insight into the upstream regulatory mechanism of NF-κB activation via UBXN1 with a primary focus on m6A modification.